• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL - DIABETES CARE BD ULTRA-FINE¿ INSULIN SYRINGE; PISTON SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL - DIABETES CARE BD ULTRA-FINE¿ INSULIN SYRINGE; PISTON SYRINGE Back to Search Results
Catalog Number 326675
Device Problem Missing Information (4053)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/08/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that 9 bd ultra-fine¿ insulin syringes were missing the lot number on their labeling.The following information was provided by the initial reporter: "missing lot number.".
 
Manufacturer Narrative
Investigation summary: a complaint lot history check was performed on lot # 1067894 for package printing defect.This is the 2nd related complaint for package printing defect on lot # 1067894.Relate complaints - (b)(4) a review of risk management 150rmn-0001-16 revision 15 indicates that the potential risk of this specific reported incident (syringe, package printing defect) was captured and addressed.Investigation summary: no samples were returned therefore the investigation was performed based on the photos provided.The customer returned several images of the 31gx6mm bd insulin syringe shelf carton from lot# 1067894.The customer reported missing lot information and incorrect position as well as torn box.The photos were examined, and although none of the photos shows a torn box, the photos does reveal that the printed lot number, manufacturing date, and expiration date were missing from the back of the shelf carton and printed on the front side of the shelf carton as opposed to the back, resulting in this information overlapping with the material number instead of its intended location.A review of the device history record was completed for batch# 1067894.All inspections and challenges were performed per the applicable operations qc specifications.There was one (1) notification [200960911] noted that did not pertain to the complaint.Based on the images received, embecta was able to confirm the customer¿s indicated failure of a printing defect.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.Manufacturing (holdrege) will be notified of this issue.Complaint #(b)(4) catalog #: 326725 batch #: 1067894 catalog description: syringe 0.5ml x 31g x 6mm b/p ap issue: package printing defect & shelf carton damage analysis of sample: 1.Visual inspection of the photo displays a carton with coding in the required location of the carton, however the leading line of the coding (the batch number) is printed on top of the material number that is preprinted on the carton.2.Visual inspection of the photo displays a shelf carton that has a slight tear on the top corner.The tear does not affect any of the labeling nor is large enough to allow a packaged syringe to fall through.Process: the blister pack machine packages the syringes into a sequence of individually formed pockets in the bottom web that is heat-sealed with the top web and then cut into individual blisters.Sealed blisters are then conveyed and picked and placed into a shelf carton.The full cartons are conveyed across a scale to ensure that the correct number of syringes have been placed in the carton.If an incorrect quantity is detected or the carton is not closed correctly, the full carton automatically conveys to a rework station.Upon completion of the rework, the full carton is manually introduced by the associate back into production prior to the scale investigation: if a defect is found during an inspection a quality notification is initiated.No quality notifications were written for issues relating to the packaging defect.L2l dispatches were all reviewed, and there were no maintenance dispatches that pertained to this defect during the production of this batch.Eos (end of shift) reports were reviewed, a notation was made for carton and casepack jams occurring due to the carton lids ¿curling/bending¿.This is occasionally seen from the vendor when the cartons are removed from the bulk packaging prior to being used for the packaging process.The vendor is notified when this occurs.The operator was directed to pre-bends the cartons prior to loading them into the carton erector machine.¿prebending¿ the cartons aides in cartons forming correctly prior to loading the carton with packaged syringes.However, occasionally the carton lid may come open after the syringes have been added or when conveying to the case pack.Root cause & correction: in the event the carton comes open when conveyed into the case pack and any slight damage is noted to the carton, the syringes are removed and repacked into a new carton.An inspection of the syringes in the blister is performed to ensure no damage and then repacked into a new erected carton.The new carton with syringes is to be placed onto the transfer belt prior to the scale and coding station.No coding on the carton signifies the full carton was manually introduced after the scale / coding process.Quality: complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.
 
Event Description
It was reported that 9 bd ultra-fine¿ insulin syringes were missing the lot number on their labeling.The following information was provided by the initial reporter: "missing lot number.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ULTRA-FINE¿ INSULIN SYRINGE
Type of Device
PISTON SYRINGE
Manufacturer (Section D)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
Manufacturer (Section G)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15913105
MDR Text Key305908280
Report Number1920898-2022-00840
Device Sequence Number1
Product Code FMF
UDI-Device Identifier00382906675019
UDI-Public(01)00382906675019
Combination Product (y/n)N
Reporter Country CodeTH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number326675
Device Lot Number1067894
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/08/2022
Initial Date FDA Received12/05/2022
Supplement Dates Manufacturer Received12/09/2022
Supplement Dates FDA Received12/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-